Article citationsMore>>

Popp, A.W., Guler, S., Lamy, O., Senn, C., Buffat, H., Perrelet, R., Hans, D. and Lippuner, K. (2013) Effects of Zoledronate versus Placebo on Spine Bone Mineral Density and Microarchitecture Assessed by the Trabecular Bone Score in Postmenopausal Women with Osteoporosis: A Three-Year Study. Journal of Bone and Mineral Research, 28, 449-454.
https://doi.org/10.1002/jbmr.1775

has been cited by the following article:

• TITLE: Use of an Electroacoustic Device and Bone Densitometry in the Diagnosis of Osteoporosis: Utility, Validation, and Comparison

  AUTHORS: Teodoro Cordova-Fraga, Martha Alicia Hernandez-Gonzalez, Angelica Hernandez-Rayas, Daniel Alberto Ponce-Covarrubias

  KEYWORDS: Electroacoustic Device, New Diagnostic Tests, Densitometry

  JOURNAL NAME: Open Journal of Applied Sciences, Vol.10 No.5, May 13, 2020

  ABSTRACT: According to the World Health Organization (WHO), men and women older than 50 years present osteoporosis with reduced bone mass, this is one of the major impact morbidities causes in the world. It may be present in the hip, spine, and wrist. The gold standard technique for osteoporosis diagnosis is the Bone Densitometry (DXA). The evaluation of an electroacoustic device is as an alternative procedure for the validation and diagnosis of osteoporosis. Diagnosis of osteoporosis severity was carried out in 49 females by using the registers of the DEXA’s T-Score values. These were statistically compared with the measurements performed using the electroacoustic device. Non-Significative difference between measurements was found with ANOVA and Chi-square tests and the area for the ROC curve on electroacoustic devices was 0.551. The Bland Altman suggests an excellent concordance between both techniques. This is a non-invasive method that has a proper match with the gold standard. The study suggests that procedure measurements with the electroacoustic device could be implemented as an alternative clinical practice for osteoporosis diagnosis.